SKLB-677 potently inhibited the viability of FLT3-driven AML cell lines, MV4-11 and Molm-13, with IC50 values of 0.079 nM and 0.116 nM, respectively (Table 2 and Fig. 1d). This evidence concerns the gene FLT3 and acute myeloid leukemia.